SARINYAPINNGAM/iStock via Getty Images
Telix Pharmaceuticals (OTCPK:TLPPF) is set to enhance its North American manufacturing footprint and establish the basis of a “next generation radiometal production network” by acquiring RLS, America’s only Joint Commission-accredited radiopharmacy network, from its parent company, RLS Group Ltd., for $250M.
The purchase
